

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | modulation by symbiont of host defense response (GO:0052031) | 6.07516797 |
| 2 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.07516797 |
| 3 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.07516797 |
| 4 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.07516797 |
| 5 | modulation by symbiont of host immune response (GO:0052553) | 6.07516797 |
| 6 | positive regulation by symbiont of host defense response (GO:0052509) | 6.07516797 |
| 7 | positive regulation of chemokine biosynthetic process (GO:0045080) | 5.52837336 |
| 8 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.11774065 |
| 9 | negative regulation of cell killing (GO:0031342) | 5.11774065 |
| 10 | detection of other organism (GO:0098543) | 4.84889137 |
| 11 | response to peptidoglycan (GO:0032494) | 4.83347373 |
| 12 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.68429489 |
| 13 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.44398970 |
| 14 | neutrophil activation involved in immune response (GO:0002283) | 4.39288959 |
| 15 | respiratory burst (GO:0045730) | 4.29187922 |
| 16 | regulation of chemokine biosynthetic process (GO:0045073) | 4.22633496 |
| 17 | response to host immune response (GO:0052572) | 4.21993718 |
| 18 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.21993718 |
| 19 | low-density lipoprotein particle clearance (GO:0034383) | 4.14408617 |
| 20 | macrophage activation involved in immune response (GO:0002281) | 4.13278329 |
| 21 | leukocyte aggregation (GO:0070486) | 4.10779654 |
| 22 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 4.10108841 |
| 23 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 4.03516618 |
| 24 | regulation of gamma-delta T cell activation (GO:0046643) | 3.97563302 |
| 25 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.93700162 |
| 26 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.91547545 |
| 27 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.91547545 |
| 28 | cellular extravasation (GO:0045123) | 3.88378734 |
| 29 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.88320409 |
| 30 | immunoglobulin mediated immune response (GO:0016064) | 3.88286001 |
| 31 | T-helper 1 type immune response (GO:0042088) | 3.87074019 |
| 32 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.85406890 |
| 33 | response to host (GO:0075136) | 3.85406890 |
| 34 | response to host defenses (GO:0052200) | 3.85406890 |
| 35 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.83723302 |
| 36 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.77517171 |
| 37 | positive regulation of humoral immune response (GO:0002922) | 3.74600671 |
| 38 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.72395606 |
| 39 | positive regulation of interferon-alpha production (GO:0032727) | 3.72164172 |
| 40 | germinal center formation (GO:0002467) | 3.69934808 |
| 41 | regulation of interferon-alpha production (GO:0032647) | 3.69152939 |
| 42 | negative regulation of interleukin-12 production (GO:0032695) | 3.67992232 |
| 43 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.61121180 |
| 44 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.60703639 |
| 45 | microglial cell activation (GO:0001774) | 3.57073923 |
| 46 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.56480450 |
| 47 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.56264820 |
| 48 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.55842711 |
| 49 | myeloid leukocyte mediated immunity (GO:0002444) | 3.53777967 |
| 50 | positive regulation of antigen processing and presentation (GO:0002579) | 3.51685133 |
| 51 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 3.47369522 |
| 52 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.44544083 |
| 53 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.44470850 |
| 54 | defense response to protozoan (GO:0042832) | 3.44248549 |
| 55 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.43688882 |
| 56 | reactive oxygen species biosynthetic process (GO:1903409) | 3.40756348 |
| 57 | granulocyte activation (GO:0036230) | 3.38793164 |
| 58 | neutrophil activation (GO:0042119) | 3.36864682 |
| 59 | regulation of podosome assembly (GO:0071801) | 3.34947834 |
| 60 | negative regulation of T cell mediated immunity (GO:0002710) | 3.34611762 |
| 61 | plasma lipoprotein particle clearance (GO:0034381) | 3.33312763 |
| 62 | detection of molecule of bacterial origin (GO:0032490) | 3.29923558 |
| 63 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.27621904 |
| 64 | neutrophil chemotaxis (GO:0030593) | 3.23498402 |
| 65 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.22302471 |
| 66 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.21884529 |
| 67 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.21884529 |
| 68 | response to interleukin-15 (GO:0070672) | 3.21041536 |
| 69 | negative regulation of mast cell activation (GO:0033004) | 3.20200155 |
| 70 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.18626015 |
| 71 | regulation of mast cell degranulation (GO:0043304) | 3.17233202 |
| 72 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.15432930 |
| 73 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.15432930 |
| 74 | neutrophil migration (GO:1990266) | 3.15073219 |
| 75 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.15024146 |
| 76 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.15024146 |
| 77 | regulation of growth of symbiont in host (GO:0044126) | 3.15024146 |
| 78 | negative regulation of growth of symbiont in host (GO:0044130) | 3.15024146 |
| 79 | response to muramyl dipeptide (GO:0032495) | 3.13530312 |
| 80 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.11354987 |
| 81 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.11043984 |
| 82 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.09837928 |
| 83 | response to protozoan (GO:0001562) | 3.09199282 |
| 84 | killing of cells of other organism (GO:0031640) | 3.07502704 |
| 85 | disruption of cells of other organism (GO:0044364) | 3.07502704 |
| 86 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.07287905 |
| 87 | positive regulation of mast cell degranulation (GO:0043306) | 3.07287905 |
| 88 | cellular response to type I interferon (GO:0071357) | 3.06594236 |
| 89 | type I interferon signaling pathway (GO:0060337) | 3.06594236 |
| 90 | neutrophil mediated immunity (GO:0002446) | 3.05498421 |
| 91 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.04759561 |
| 92 | response to type I interferon (GO:0034340) | 3.03963026 |
| 93 | myeloid leukocyte activation (GO:0002274) | 3.03554730 |
| 94 | negative regulation of interleukin-1 beta production (GO:0032691) | 3.02763077 |
| 95 | macrophage activation (GO:0042116) | 3.02504225 |
| 96 | negative regulation of interleukin-17 production (GO:0032700) | 3.02371004 |
| 97 | positive regulation of mast cell activation (GO:0033005) | 3.02214580 |
| 98 | regulation of fever generation (GO:0031620) | 3.01900712 |
| 99 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.01892266 |
| 100 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 3.00532822 |
| 101 | negative regulation of interleukin-6 production (GO:0032715) | 3.00342969 |
| 102 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.99306620 |
| 103 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.98574702 |
| 104 | superoxide anion generation (GO:0042554) | 2.98038098 |
| 105 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.97739235 |
| 106 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.97528156 |
| 107 | positive regulation of heat generation (GO:0031652) | 2.96801993 |
| 108 | regulation of macrophage cytokine production (GO:0010935) | 2.96120889 |
| 109 | regulation of antigen processing and presentation (GO:0002577) | 2.96004849 |
| 110 | regulation of leukocyte degranulation (GO:0043300) | 2.93017096 |
| 111 | NIK/NF-kappaB signaling (GO:0038061) | 2.92451404 |
| 112 | leukocyte degranulation (GO:0043299) | 2.91892543 |
| 113 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.91739038 |
| 114 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.91324301 |
| 115 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.90477057 |
| 116 | B cell mediated immunity (GO:0019724) | 2.89821838 |
| 117 | detection of external biotic stimulus (GO:0098581) | 2.88926229 |
| 118 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.88481700 |
| 119 | positive regulation of interferon-beta production (GO:0032728) | 2.88121446 |
| 120 | regulation of toll-like receptor signaling pathway (GO:0034121) | 2.87585636 |
| 121 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.85441779 |
| 122 | protein carboxylation (GO:0018214) | 2.85441779 |
| 123 | complement activation, alternative pathway (GO:0006957) | 2.84225284 |
| 124 | leukocyte mediated cytotoxicity (GO:0001909) | 2.82655586 |
| 125 | positive regulation of macrophage cytokine production (GO:0060907) | 2.82245693 |
| 126 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.81404557 |
| 127 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.81169749 |
| 128 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.80628407 |
| 129 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.79980313 |
| 130 | cellular response to interleukin-15 (GO:0071350) | 2.79720085 |
| 131 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.79301210 |
| 132 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.78595102 |
| 133 | regulation of mast cell activation (GO:0033003) | 2.77633803 |
| 134 | negative regulation of lipid storage (GO:0010888) | 2.76086745 |
| 135 | myeloid cell activation involved in immune response (GO:0002275) | 2.75598287 |
| 136 | urea metabolic process (GO:0019627) | 2.75027139 |
| 137 | urea cycle (GO:0000050) | 2.75027139 |
| 138 | detection of bacterium (GO:0016045) | 2.74727832 |
| 139 | regulation of chronic inflammatory response (GO:0002676) | 2.74025768 |
| 140 | cytokine secretion (GO:0050663) | 2.70704400 |
| 141 | acute-phase response (GO:0006953) | 2.70319927 |
| 142 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.69685771 |
| 143 | detection of biotic stimulus (GO:0009595) | 2.69307884 |
| 144 | I-kappaB phosphorylation (GO:0007252) | 2.68927059 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.02316020 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.52758426 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.93678519 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.25233153 |
| 5 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.70372504 |
| 6 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.59136451 |
| 7 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.57503843 |
| 8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.40024880 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.39910406 |
| 10 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.31300622 |
| 11 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.25501153 |
| 12 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.19432704 |
| 13 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.17326199 |
| 14 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.09721275 |
| 15 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.06464485 |
| 16 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.99059363 |
| 17 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.95572119 |
| 18 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.95535485 |
| 19 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.85855596 |
| 20 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.55369695 |
| 21 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.54642904 |
| 22 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.49223899 |
| 23 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.47220198 |
| 24 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.33367729 |
| 25 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.32504009 |
| 26 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.24146152 |
| 27 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.23588710 |
| 28 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.23495615 |
| 29 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.20528769 |
| 30 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.20371990 |
| 31 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.00315500 |
| 32 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.85454951 |
| 33 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.79802864 |
| 34 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.79412174 |
| 35 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.73596816 |
| 36 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.72045702 |
| 37 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.69955502 |
| 38 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.67775978 |
| 39 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.66391243 |
| 40 | MAF_26560356_Chip-Seq_TH1_Human | 1.66261791 |
| 41 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.65291909 |
| 42 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.59917986 |
| 43 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.59333498 |
| 44 | GATA1_22025678_ChIP-Seq_K562_Human | 1.54976952 |
| 45 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.54921962 |
| 46 | MYB_26560356_Chip-Seq_TH2_Human | 1.51458586 |
| 47 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.49988899 |
| 48 | SPI1_23127762_ChIP-Seq_K562_Human | 1.48695763 |
| 49 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.44574908 |
| 50 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.44234801 |
| 51 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.41599751 |
| 52 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.39494068 |
| 53 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.38302579 |
| 54 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.37413669 |
| 55 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.36930210 |
| 56 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32721080 |
| 57 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.29973486 |
| 58 | MYB_26560356_Chip-Seq_TH1_Human | 1.28018340 |
| 59 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.27244242 |
| 60 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.24744469 |
| 61 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.23357689 |
| 62 | GATA1_19941826_ChIP-Seq_K562_Human | 1.21089657 |
| 63 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.20871753 |
| 64 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.17899709 |
| 65 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.17764605 |
| 66 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.16112005 |
| 67 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13644893 |
| 68 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.12845886 |
| 69 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.12326508 |
| 70 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.12191063 |
| 71 | UTX_26944678_Chip-Seq_JUKART_Human | 1.11490139 |
| 72 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10948419 |
| 73 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09034871 |
| 74 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08942874 |
| 75 | GATA2_19941826_ChIP-Seq_K562_Human | 1.06706097 |
| 76 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.05657650 |
| 77 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.05400768 |
| 78 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.04918939 |
| 79 | GATA3_26560356_Chip-Seq_TH2_Human | 1.04399805 |
| 80 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.03584103 |
| 81 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.01988824 |
| 82 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.01390480 |
| 83 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00935316 |
| 84 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.00150608 |
| 85 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99877210 |
| 86 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.94390657 |
| 87 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.94312493 |
| 88 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.93234307 |
| 89 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.92450024 |
| 90 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.91250438 |
| 91 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.90973960 |
| 92 | MAF_26560356_Chip-Seq_TH2_Human | 0.90915533 |
| 93 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90750927 |
| 94 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90358419 |
| 95 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.88667117 |
| 96 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.85432365 |
| 97 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.85432365 |
| 98 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.84293083 |
| 99 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.84085344 |
| 100 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.83746836 |
| 101 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.82701544 |
| 102 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.82527797 |
| 103 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.82111548 |
| 104 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.81072197 |
| 105 | MYC_22102868_ChIP-Seq_BL_Human | 0.80608282 |
| 106 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.80051741 |
| 107 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.78755444 |
| 108 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.77196135 |
| 109 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.76900317 |
| 110 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.76841813 |
| 111 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.76740361 |
| 112 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.75745578 |
| 113 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.75411494 |
| 114 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.72889408 |
| 115 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.71156176 |
| 116 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.70519941 |
| 117 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.70285287 |
| 118 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.65942327 |
| 119 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.65013604 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.02602957 |
| 2 | MP0009785_altered_susceptibility_to | 3.61707791 |
| 3 | MP0003436_decreased_susceptibility_to | 3.45686937 |
| 4 | MP0002139_abnormal_hepatobiliary_system | 3.27513573 |
| 5 | MP0003303_peritoneal_inflammation | 3.24330464 |
| 6 | MP0002419_abnormal_innate_immunity | 2.97557584 |
| 7 | MP0005360_urolithiasis | 2.92689951 |
| 8 | MP0003724_increased_susceptibility_to | 2.82681637 |
| 9 | MP0004510_myositis | 2.81528745 |
| 10 | MP0005025_abnormal_response_to | 2.66757199 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.62825063 |
| 12 | MP0009840_abnormal_foam_cell | 2.59922841 |
| 13 | MP0000685_abnormal_immune_system | 2.56759118 |
| 14 | MP0001790_abnormal_immune_system | 2.56634187 |
| 15 | MP0005387_immune_system_phenotype | 2.56634187 |
| 16 | MP0002148_abnormal_hypersensitivity_rea | 2.52698407 |
| 17 | MP0002452_abnormal_antigen_presenting | 2.29677628 |
| 18 | MP0005085_abnormal_gallbladder_physiolo | 2.29290464 |
| 19 | MP0001800_abnormal_humoral_immune | 2.26826311 |
| 20 | MP0009764_decreased_sensitivity_to | 2.26087502 |
| 21 | MP0005671_abnormal_response_to | 2.25820599 |
| 22 | MP0005365_abnormal_bile_salt | 2.22569502 |
| 23 | MP0006082_CNS_inflammation | 2.12704998 |
| 24 | MP0002138_abnormal_hepatobiliary_system | 2.12396797 |
| 25 | MP0002723_abnormal_immune_serum | 2.11405250 |
| 26 | MP0003191_abnormal_cellular_cholesterol | 2.05849979 |
| 27 | MP0005464_abnormal_platelet_physiology | 2.02516090 |
| 28 | MP0008004_abnormal_stomach_pH | 1.95900925 |
| 29 | MP0001845_abnormal_inflammatory_respons | 1.91758912 |
| 30 | MP0004947_skin_inflammation | 1.90603905 |
| 31 | MP0001819_abnormal_immune_cell | 1.89612572 |
| 32 | MP0009278_abnormal_bone_marrow | 1.87954695 |
| 33 | MP0002420_abnormal_adaptive_immunity | 1.87162623 |
| 34 | MP0002132_abnormal_respiratory_system | 1.82532958 |
| 35 | MP0003806_abnormal_nucleotide_metabolis | 1.81498668 |
| 36 | MP0008469_abnormal_protein_level | 1.79128783 |
| 37 | MP0008875_abnormal_xenobiotic_pharmacok | 1.77556126 |
| 38 | MP0001853_heart_inflammation | 1.76184685 |
| 39 | MP0002405_respiratory_system_inflammati | 1.75920830 |
| 40 | MP0001533_abnormal_skeleton_physiology | 1.75883970 |
| 41 | MP0000343_altered_response_to | 1.71659513 |
| 42 | MP0003075_altered_response_to | 1.60055972 |
| 43 | MP0000465_gastrointestinal_hemorrhage | 1.58183686 |
| 44 | MP0003186_abnormal_redox_activity | 1.56456562 |
| 45 | MP0005451_abnormal_body_composition | 1.56280470 |
| 46 | MP0000569_abnormal_digit_pigmentation | 1.55475411 |
| 47 | MP0003656_abnormal_erythrocyte_physiolo | 1.55078631 |
| 48 | MP0005167_abnormal_blood-brain_barrier | 1.53156361 |
| 49 | MP0003195_calcinosis | 1.46872003 |
| 50 | MP0009333_abnormal_splenocyte_physiolog | 1.45406184 |
| 51 | MP0003252_abnormal_bile_duct | 1.44297180 |
| 52 | MP0010155_abnormal_intestine_physiology | 1.44038162 |
| 53 | MP0002277_abnormal_respiratory_mucosa | 1.41444015 |
| 54 | MP0010329_abnormal_lipoprotein_level | 1.38837725 |
| 55 | MP0003300_gastrointestinal_ulcer | 1.38056689 |
| 56 | MP0000609_abnormal_liver_physiology | 1.36466703 |
| 57 | MP0000716_abnormal_immune_system | 1.33492219 |
| 58 | MP0003763_abnormal_thymus_physiology | 1.32057133 |
| 59 | MP0002332_abnormal_exercise_endurance | 1.28371976 |
| 60 | MP0004381_abnormal_hair_follicle | 1.27100603 |
| 61 | MP0005083_abnormal_biliary_tract | 1.25429248 |
| 62 | MP0002006_tumorigenesis | 1.25211375 |
| 63 | MP0005058_abnormal_lysosome_morphology | 1.24719936 |
| 64 | MP0009763_increased_sensitivity_to | 1.23812022 |
| 65 | MP0005397_hematopoietic_system_phenotyp | 1.22947416 |
| 66 | MP0001545_abnormal_hematopoietic_system | 1.22947416 |
| 67 | MP0002398_abnormal_bone_marrow | 1.22685867 |
| 68 | MP0003448_altered_tumor_morphology | 1.21859285 |
| 69 | MP0000689_abnormal_spleen_morphology | 1.18052912 |
| 70 | MP0000604_amyloidosis | 1.17904979 |
| 71 | MP0005319_abnormal_enzyme/_coenzyme | 1.15798863 |
| 72 | MP0003453_abnormal_keratinocyte_physiol | 1.13115856 |
| 73 | MP0005076_abnormal_cell_differentiation | 1.12683973 |
| 74 | MP0002396_abnormal_hematopoietic_system | 1.12503564 |
| 75 | MP0003866_abnormal_defecation | 1.10064186 |
| 76 | MP0002429_abnormal_blood_cell | 1.08391053 |
| 77 | MP0005310_abnormal_salivary_gland | 1.03915918 |
| 78 | MP0005332_abnormal_amino_acid | 1.03152380 |
| 79 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.03043030 |
| 80 | MP0005164_abnormal_response_to | 1.02864631 |
| 81 | MP0002254_reproductive_system_inflammat | 1.02846127 |
| 82 | MP0002722_abnormal_immune_system | 1.02403759 |
| 83 | MP0005166_decreased_susceptibility_to | 1.02320971 |
| 84 | MP0002166_altered_tumor_susceptibility | 1.00383651 |
| 85 | MP0003172_abnormal_lysosome_physiology | 0.99310311 |
| 86 | MP0000858_altered_metastatic_potential | 0.98131912 |
| 87 | MP0000703_abnormal_thymus_morphology | 0.96593424 |
| 88 | MP0002998_abnormal_bone_remodeling | 0.95174407 |
| 89 | MP0002118_abnormal_lipid_homeostasis | 0.91238100 |
| 90 | MP0004808_abnormal_hematopoietic_stem | 0.89307523 |
| 91 | MP0003045_fibrosis | 0.88569323 |
| 92 | MP0000598_abnormal_liver_morphology | 0.86878473 |
| 93 | MP0004883_abnormal_blood_vessel | 0.85427697 |
| 94 | MP0001666_abnormal_nutrient_absorption | 0.83415577 |
| 95 | MP0000015_abnormal_ear_pigmentation | 0.82921738 |
| 96 | MP0002933_joint_inflammation | 0.82159088 |
| 97 | MP0000249_abnormal_blood_vessel | 0.81858426 |
| 98 | MP0001663_abnormal_digestive_system | 0.79985775 |
| 99 | MP0004019_abnormal_vitamin_homeostasis | 0.79111981 |
| 100 | MP0003183_abnormal_peptide_metabolism | 0.78455090 |
| 101 | MP0004484_altered_response_of | 0.76788106 |
| 102 | MP0006054_spinal_hemorrhage | 0.74991684 |
| 103 | MP0001851_eye_inflammation | 0.74937892 |
| 104 | MP0002136_abnormal_kidney_physiology | 0.74571748 |
| 105 | MP0005390_skeleton_phenotype | 0.73863289 |
| 106 | MP0001873_stomach_inflammation | 0.72537597 |
| 107 | MP0010352_gastrointestinal_tract_polyps | 0.71038761 |
| 108 | MP0009765_abnormal_xenobiotic_induced | 0.70688778 |
| 109 | MP0001764_abnormal_homeostasis | 0.69762724 |
| 110 | MP0003690_abnormal_glial_cell | 0.68448392 |
| 111 | MP0008874_decreased_physiological_sensi | 0.67593087 |
| 112 | MP0005535_abnormal_body_temperature | 0.66463629 |
| 113 | MP0008260_abnormal_autophagy | 0.66222973 |
| 114 | MP0009643_abnormal_urine_homeostasis | 0.65676804 |
| 115 | MP0003091_abnormal_cell_migration | 0.65207475 |
| 116 | MP0003705_abnormal_hypodermis_morpholog | 0.64682905 |
| 117 | MP0004130_abnormal_muscle_cell | 0.64444768 |
| 118 | MP0003828_pulmonary_edema | 0.63870505 |
| 119 | MP0005023_abnormal_wound_healing | 0.63783590 |
| 120 | MP0009642_abnormal_blood_homeostasis | 0.63703953 |
| 121 | MP0003221_abnormal_cardiomyocyte_apopto | 0.63557981 |
| 122 | MP0003795_abnormal_bone_structure | 0.60063664 |
| 123 | MP0005376_homeostasis/metabolism_phenot | 0.57037809 |
| 124 | MP0000920_abnormal_myelination | 0.50601669 |
| 125 | MP0005174_abnormal_tail_pigmentation | 0.49759059 |
| 126 | MP0005377_hearing/vestibular/ear_phenot | 0.48952891 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent gram-negative bacterial infections (HP:0005420) | 6.50012542 |
| 2 | Recurrent abscess formation (HP:0002722) | 6.42164237 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 5.97974951 |
| 4 | Eczematoid dermatitis (HP:0000976) | 5.96907681 |
| 5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.82177018 |
| 6 | Stomatitis (HP:0010280) | 4.80970386 |
| 7 | Abnormality of macrophages (HP:0004311) | 4.55461104 |
| 8 | Orchitis (HP:0100796) | 4.14229765 |
| 9 | Myositis (HP:0100614) | 4.03644270 |
| 10 | Mediastinal lymphadenopathy (HP:0100721) | 4.02807536 |
| 11 | Retrobulbar optic neuritis (HP:0100654) | 4.00526842 |
| 12 | Optic neuritis (HP:0100653) | 4.00526842 |
| 13 | Amyloidosis (HP:0011034) | 3.89383866 |
| 14 | Autoimmune thrombocytopenia (HP:0001973) | 3.72008228 |
| 15 | Recurrent skin infections (HP:0001581) | 3.67421382 |
| 16 | Joint hemorrhage (HP:0005261) | 3.66458398 |
| 17 | Deep venous thrombosis (HP:0002625) | 3.65767562 |
| 18 | Prolonged partial thromboplastin time (HP:0003645) | 3.56461272 |
| 19 | Gingivitis (HP:0000230) | 3.55109770 |
| 20 | Urticaria (HP:0001025) | 3.49720777 |
| 21 | Chronic obstructive pulmonary disease (HP:0006510) | 3.49348699 |
| 22 | Obstructive lung disease (HP:0006536) | 3.49348699 |
| 23 | Systemic lupus erythematosus (HP:0002725) | 3.48742249 |
| 24 | Gingival bleeding (HP:0000225) | 3.42421506 |
| 25 | Abnormality of the common coagulation pathway (HP:0010990) | 3.38882486 |
| 26 | Increased IgE level (HP:0003212) | 3.33960746 |
| 27 | Gastrointestinal infarctions (HP:0005244) | 3.33472717 |
| 28 | Vasculitis (HP:0002633) | 3.32151816 |
| 29 | Episodic fever (HP:0001954) | 3.23500921 |
| 30 | Prolonged bleeding time (HP:0003010) | 3.22370454 |
| 31 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.21343625 |
| 32 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.16216347 |
| 33 | Myocardial infarction (HP:0001658) | 3.12846752 |
| 34 | T lymphocytopenia (HP:0005403) | 3.08600153 |
| 35 | Chest pain (HP:0100749) | 3.07845345 |
| 36 | Complement deficiency (HP:0004431) | 3.05613336 |
| 37 | Peritonitis (HP:0002586) | 2.98634911 |
| 38 | Intrahepatic cholestasis (HP:0001406) | 2.98138353 |
| 39 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.97792100 |
| 40 | Recurrent fungal infections (HP:0002841) | 2.95215698 |
| 41 | Interstitial pulmonary disease (HP:0006530) | 2.93614049 |
| 42 | Increased IgM level (HP:0003496) | 2.92256270 |
| 43 | Increased cerebral lipofuscin (HP:0011813) | 2.92089555 |
| 44 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.91937868 |
| 45 | Xanthomatosis (HP:0000991) | 2.90895849 |
| 46 | Glomerulonephritis (HP:0000099) | 2.90642200 |
| 47 | Abnormality of complement system (HP:0005339) | 2.88087972 |
| 48 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.87914079 |
| 49 | Keratoconjunctivitis sicca (HP:0001097) | 2.78852140 |
| 50 | Pustule (HP:0200039) | 2.78147007 |
| 51 | Tetraparesis (HP:0002273) | 2.77589232 |
| 52 | Meningitis (HP:0001287) | 2.75758983 |
| 53 | Chronic otitis media (HP:0000389) | 2.69004628 |
| 54 | Anorexia (HP:0002039) | 2.67156256 |
| 55 | Cellulitis (HP:0100658) | 2.65721480 |
| 56 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.64741413 |
| 57 | Arterial thrombosis (HP:0004420) | 2.64455043 |
| 58 | Spontaneous hematomas (HP:0007420) | 2.64022445 |
| 59 | Pulmonary embolism (HP:0002204) | 2.61734107 |
| 60 | Pulmonary infiltrates (HP:0002113) | 2.59626239 |
| 61 | Periodontitis (HP:0000704) | 2.57966505 |
| 62 | Abnormality of iron homeostasis (HP:0011031) | 2.57840895 |
| 63 | Vacuolated lymphocytes (HP:0001922) | 2.57064228 |
| 64 | Keratoconjunctivitis (HP:0001096) | 2.52250762 |
| 65 | Nausea (HP:0002018) | 2.51727122 |
| 66 | Esophageal varix (HP:0002040) | 2.50879583 |
| 67 | Abnormality of the endocardium (HP:0004306) | 2.50283575 |
| 68 | Abnormality of the peritoneum (HP:0002585) | 2.48119528 |
| 69 | Petechiae (HP:0000967) | 2.47364021 |
| 70 | Recurrent viral infections (HP:0004429) | 2.45045140 |
| 71 | Increased serum ferritin (HP:0003281) | 2.44299836 |
| 72 | Joint swelling (HP:0001386) | 2.44188671 |
| 73 | Hyperlipoproteinemia (HP:0010980) | 2.40721185 |
| 74 | Nephritis (HP:0000123) | 2.40385888 |
| 75 | Thrombophlebitis (HP:0004418) | 2.39749192 |
| 76 | Hypobetalipoproteinemia (HP:0003563) | 2.38834603 |
| 77 | Epistaxis (HP:0000421) | 2.37638178 |
| 78 | Hematochezia (HP:0002573) | 2.36215731 |
| 79 | Keratitis (HP:0000491) | 2.36051141 |
| 80 | Hemoptysis (HP:0002105) | 2.36044943 |
| 81 | Vertigo (HP:0002321) | 2.35191572 |
| 82 | Leukocytosis (HP:0001974) | 2.35059173 |
| 83 | Glomerulopathy (HP:0100820) | 2.28832222 |
| 84 | Purpura (HP:0000979) | 2.28819801 |
| 85 | Abnormality of T cells (HP:0002843) | 2.24683994 |
| 86 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.23964549 |
| 87 | Inflammation of the large intestine (HP:0002037) | 2.22059826 |
| 88 | Sepsis (HP:0100806) | 2.21293770 |
| 89 | Hydroxyprolinuria (HP:0003080) | 2.20586906 |
| 90 | Abnormality of proline metabolism (HP:0010907) | 2.20586906 |
| 91 | Mitral stenosis (HP:0001718) | 2.19973118 |
| 92 | Loss of speech (HP:0002371) | 2.19705225 |
| 93 | Granulocytopenia (HP:0001913) | 2.18920568 |
| 94 | Axonal loss (HP:0003447) | 2.18231549 |
| 95 | Menorrhagia (HP:0000132) | 2.17420997 |
| 96 | Acne (HP:0001061) | 2.14864918 |
| 97 | Subacute progressive viral hepatitis (HP:0006572) | 2.14787805 |
| 98 | Slow saccadic eye movements (HP:0000514) | 2.10193457 |
| 99 | Eosinophilia (HP:0001880) | 2.08026914 |
| 100 | Hypochromic anemia (HP:0001931) | 2.07461407 |
| 101 | Colitis (HP:0002583) | 2.06295162 |
| 102 | Gastrointestinal inflammation (HP:0004386) | 2.05915082 |
| 103 | Hypergammaglobulinemia (HP:0010702) | 2.05250698 |
| 104 | Disinhibition (HP:0000734) | 2.03393243 |
| 105 | Osteomyelitis (HP:0002754) | 2.03165133 |
| 106 | Encephalitis (HP:0002383) | 2.02863521 |
| 107 | Polyneuropathy (HP:0001271) | 2.01476757 |
| 108 | Hypercholesterolemia (HP:0003124) | 2.01309284 |
| 109 | Abnormality of the pericardium (HP:0001697) | 1.99870205 |
| 110 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.99665786 |
| 111 | Hypochromic microcytic anemia (HP:0004840) | 1.99298979 |
| 112 | Thick nail (HP:0001805) | 1.99146432 |
| 113 | Fat malabsorption (HP:0002630) | 1.97674050 |
| 114 | Epidermoid cyst (HP:0200040) | 1.93132651 |
| 115 | Hepatosplenomegaly (HP:0001433) | 1.92046633 |
| 116 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.91264562 |
| 117 | Abnormal platelet volume (HP:0011876) | 1.90586123 |
| 118 | Acute hepatic failure (HP:0006554) | 1.90372854 |
| 119 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.89899378 |
| 120 | Recurrent cutaneous fungal infections (HP:0011370) | 1.89899378 |
| 121 | Gangrene (HP:0100758) | 1.89846773 |
| 122 | Autoimmune hemolytic anemia (HP:0001890) | 1.87883477 |
| 123 | Hyperammonemia (HP:0001987) | 1.87768379 |
| 124 | Hemorrhage of the eye (HP:0011885) | 1.86995747 |
| 125 | Polycythemia (HP:0001901) | 1.85623052 |
| 126 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.83754626 |
| 127 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.83754626 |
| 128 | Abnormality of glycolipid metabolism (HP:0010969) | 1.83754626 |
| 129 | Cheilitis (HP:0100825) | 1.83677405 |
| 130 | Abnormality of the pleura (HP:0002103) | 1.82891058 |
| 131 | Recurrent pneumonia (HP:0006532) | 1.82784450 |
| 132 | Abnormality of T cell number (HP:0011839) | 1.82341066 |
| 133 | Premature loss of primary teeth (HP:0006323) | 1.82304334 |
| 134 | Viral hepatitis (HP:0006562) | 1.81808293 |
| 135 | Amaurosis fugax (HP:0100576) | 1.79827856 |
| 136 | Skin ulcer (HP:0200042) | 1.79493970 |
| 137 | Microcytic anemia (HP:0001935) | 1.77983245 |
| 138 | Arthralgia (HP:0002829) | 1.74679760 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 5.23559725 |
| 2 | TBK1 | 3.88665003 |
| 3 | RIPK4 | 3.87446844 |
| 4 | IRAK3 | 3.17615192 |
| 5 | MAP4K1 | 3.12386554 |
| 6 | TYK2 | 2.98374983 |
| 7 | IRAK4 | 2.97892597 |
| 8 | BLK | 2.87220275 |
| 9 | ERN1 | 2.63910627 |
| 10 | IKBKE | 2.60454984 |
| 11 | CSK | 2.53925486 |
| 12 | IKBKB | 2.48395673 |
| 13 | IRAK1 | 2.17896681 |
| 14 | EPHB1 | 1.97995592 |
| 15 | IRAK2 | 1.96112440 |
| 16 | JAK3 | 1.91965616 |
| 17 | KIT | 1.85955875 |
| 18 | FGR | 1.84984605 |
| 19 | TXK | 1.83228466 |
| 20 | FGFR4 | 1.78030505 |
| 21 | STK10 | 1.74645296 |
| 22 | JAK1 | 1.71453577 |
| 23 | PBK | 1.62091392 |
| 24 | TNK2 | 1.53558594 |
| 25 | RIPK1 | 1.53551599 |
| 26 | CHUK | 1.51264174 |
| 27 | MAP3K13 | 1.50903167 |
| 28 | PRPF4B | 1.48152162 |
| 29 | GRK6 | 1.43737021 |
| 30 | CSF1R | 1.38511060 |
| 31 | TAOK3 | 1.37213329 |
| 32 | ZAP70 | 1.32791171 |
| 33 | KDR | 1.32229990 |
| 34 | SYK | 1.31226448 |
| 35 | JAK2 | 1.26998846 |
| 36 | FES | 1.25455697 |
| 37 | MAP3K2 | 1.23646690 |
| 38 | TAOK2 | 1.21333759 |
| 39 | CLK1 | 1.18464376 |
| 40 | LYN | 1.15792842 |
| 41 | HCK | 1.14442520 |
| 42 | MARK3 | 1.13869178 |
| 43 | TGFBR2 | 1.12198408 |
| 44 | BTK | 1.07200049 |
| 45 | ABL2 | 1.06636887 |
| 46 | BMX | 1.05726751 |
| 47 | MAP3K6 | 1.03843899 |
| 48 | MAP3K10 | 1.02013790 |
| 49 | SIK1 | 1.01660654 |
| 50 | LRRK2 | 0.97986625 |
| 51 | MST4 | 0.97070663 |
| 52 | MARK2 | 0.93327013 |
| 53 | PIM1 | 0.92490358 |
| 54 | PTK6 | 0.87681697 |
| 55 | MAP2K3 | 0.85576678 |
| 56 | SIK3 | 0.85536560 |
| 57 | ITK | 0.84799811 |
| 58 | LCK | 0.83751436 |
| 59 | KSR2 | 0.83106583 |
| 60 | GRK7 | 0.81011262 |
| 61 | ERBB4 | 0.80106585 |
| 62 | MAP3K12 | 0.76241545 |
| 63 | MATK | 0.76201846 |
| 64 | BMPR2 | 0.76080079 |
| 65 | EIF2AK2 | 0.76069598 |
| 66 | WNK1 | 0.75657437 |
| 67 | TEC | 0.75163392 |
| 68 | ACVR1B | 0.72672718 |
| 69 | PRKG2 | 0.72180065 |
| 70 | KSR1 | 0.71747962 |
| 71 | MAP3K11 | 0.71467918 |
| 72 | RAF1 | 0.71455143 |
| 73 | FGFR3 | 0.70195441 |
| 74 | SIK2 | 0.69807753 |
| 75 | EGFR | 0.68883205 |
| 76 | CDC42BPA | 0.68737271 |
| 77 | FLT3 | 0.67119929 |
| 78 | MAP2K4 | 0.66703081 |
| 79 | MST1R | 0.66125377 |
| 80 | RPS6KA4 | 0.64845081 |
| 81 | SGK3 | 0.64624433 |
| 82 | PRKCD | 0.61828278 |
| 83 | TRIB3 | 0.57934547 |
| 84 | SGK2 | 0.57294786 |
| 85 | MAP3K1 | 0.56589004 |
| 86 | MAP2K6 | 0.56411028 |
| 87 | ABL1 | 0.55146049 |
| 88 | PRKD2 | 0.52723545 |
| 89 | DYRK3 | 0.52052691 |
| 90 | PRKCQ | 0.52041677 |
| 91 | MAPK4 | 0.51625931 |
| 92 | STK11 | 0.48999796 |
| 93 | GRK1 | 0.48880481 |
| 94 | NEK9 | 0.47827065 |
| 95 | MAPK7 | 0.47307103 |
| 96 | NLK | 0.46809902 |
| 97 | TESK2 | 0.46427468 |
| 98 | ALK | 0.45442627 |
| 99 | STK4 | 0.45170947 |
| 100 | HIPK2 | 0.44051074 |
| 101 | DYRK1B | 0.41747174 |
| 102 | MAP3K3 | 0.41730146 |
| 103 | BCKDK | 0.41616589 |
| 104 | MAPK12 | 0.41161400 |
| 105 | RET | 0.39332856 |
| 106 | EPHA3 | 0.37647280 |
| 107 | PDPK1 | 0.36596777 |
| 108 | RPS6KC1 | 0.36456769 |
| 109 | RPS6KL1 | 0.36456769 |
| 110 | MOS | 0.36361933 |
| 111 | FYN | 0.35977713 |
| 112 | PAK4 | 0.35546271 |
| 113 | PDK1 | 0.34076621 |
| 114 | MAPK11 | 0.34066413 |
| 115 | MAP3K7 | 0.33903371 |
| 116 | PIK3CG | 0.33411708 |
| 117 | RPS6KA6 | 0.33311896 |
| 118 | PRKAA2 | 0.32330473 |
| 119 | EIF2AK1 | 0.31760878 |
| 120 | DAPK2 | 0.31656549 |
| 121 | RPS6KA1 | 0.31384852 |
| 122 | DMPK | 0.31252023 |
| 123 | STK38 | 0.31043415 |
| 124 | MAP3K5 | 0.31033711 |
| 125 | YES1 | 0.30937630 |
| 126 | PTK2B | 0.30897710 |
| 127 | MAPKAPK2 | 0.29515016 |
| 128 | PRKCZ | 0.29026864 |
| 129 | INSR | 0.28469776 |
| 130 | CAMK1D | 0.28337525 |
| 131 | PKN1 | 0.28289872 |
| 132 | PDGFRB | 0.27186802 |
| 133 | CAMK4 | 0.26652443 |
| 134 | GSK3A | 0.26181825 |
| 135 | PRKCH | 0.26005074 |
| 136 | TAOK1 | 0.25540540 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 4.03552663 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 3.18025627 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.66891716 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.60794610 |
| 5 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.59220497 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.35490176 |
| 7 | Malaria_Homo sapiens_hsa05144 | 2.35437921 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.33590019 |
| 9 | Legionellosis_Homo sapiens_hsa05134 | 2.26951107 |
| 10 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.26785186 |
| 11 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.17341207 |
| 12 | African trypanosomiasis_Homo sapiens_hsa05143 | 2.13239722 |
| 13 | Allograft rejection_Homo sapiens_hsa05330 | 2.12987527 |
| 14 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.01713468 |
| 15 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.95505659 |
| 16 | Pertussis_Homo sapiens_hsa05133 | 1.92847047 |
| 17 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.80333742 |
| 18 | Asthma_Homo sapiens_hsa05310 | 1.78848605 |
| 19 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.75326784 |
| 20 | Tuberculosis_Homo sapiens_hsa05152 | 1.69287099 |
| 21 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.64729741 |
| 22 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.60955497 |
| 23 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.49728394 |
| 24 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.49060714 |
| 25 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.37727796 |
| 26 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.37418325 |
| 27 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.36289568 |
| 28 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.32362123 |
| 29 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.30209648 |
| 30 | Measles_Homo sapiens_hsa05162 | 1.28264372 |
| 31 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.28024061 |
| 32 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.25212011 |
| 33 | Influenza A_Homo sapiens_hsa05164 | 1.18990289 |
| 34 | Salmonella infection_Homo sapiens_hsa05132 | 1.16422491 |
| 35 | Histidine metabolism_Homo sapiens_hsa00340 | 1.15954046 |
| 36 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.14697350 |
| 37 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.14475288 |
| 38 | Platelet activation_Homo sapiens_hsa04611 | 1.13010030 |
| 39 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.12947086 |
| 40 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.12220802 |
| 41 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.10779141 |
| 42 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.10416260 |
| 43 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.05908557 |
| 44 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.05681210 |
| 45 | Phagosome_Homo sapiens_hsa04145 | 1.05490835 |
| 46 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.05467614 |
| 47 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.03807094 |
| 48 | Shigellosis_Homo sapiens_hsa05131 | 1.03274296 |
| 49 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.02430653 |
| 50 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.01424096 |
| 51 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.01398162 |
| 52 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.00194493 |
| 53 | Lysosome_Homo sapiens_hsa04142 | 0.98311684 |
| 54 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.97872375 |
| 55 | Peroxisome_Homo sapiens_hsa04146 | 0.97786527 |
| 56 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.96286875 |
| 57 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.96153923 |
| 58 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.94764250 |
| 59 | Other glycan degradation_Homo sapiens_hsa00511 | 0.94712139 |
| 60 | Apoptosis_Homo sapiens_hsa04210 | 0.94312527 |
| 61 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.93106126 |
| 62 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.93013917 |
| 63 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.90983973 |
| 64 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.90680516 |
| 65 | ABC transporters_Homo sapiens_hsa02010 | 0.87057557 |
| 66 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.84734028 |
| 67 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.84284223 |
| 68 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.83220037 |
| 69 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.80326710 |
| 70 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.79384190 |
| 71 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.77485427 |
| 72 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.77285314 |
| 73 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.76927740 |
| 74 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.74254858 |
| 75 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.73954234 |
| 76 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.73729824 |
| 77 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.73565970 |
| 78 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.72612634 |
| 79 | Hepatitis C_Homo sapiens_hsa05160 | 0.72536706 |
| 80 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.69905722 |
| 81 | Amoebiasis_Homo sapiens_hsa05146 | 0.69488297 |
| 82 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.69405700 |
| 83 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.68922146 |
| 84 | Prion diseases_Homo sapiens_hsa05020 | 0.67518606 |
| 85 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.67331324 |
| 86 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.65881698 |
| 87 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.65635367 |
| 88 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.65053390 |
| 89 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.64866498 |
| 90 | Endometrial cancer_Homo sapiens_hsa05213 | 0.61956828 |
| 91 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.61926796 |
| 92 | Hepatitis B_Homo sapiens_hsa05161 | 0.61757346 |
| 93 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.61328963 |
| 94 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.60891540 |
| 95 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.60613213 |
| 96 | Endocytosis_Homo sapiens_hsa04144 | 0.60285614 |
| 97 | Retinol metabolism_Homo sapiens_hsa00830 | 0.59806558 |
| 98 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.59422436 |
| 99 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.59136577 |
| 100 | Bladder cancer_Homo sapiens_hsa05219 | 0.59128515 |
| 101 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.58866457 |
| 102 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.58135133 |
| 103 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.57922179 |
| 104 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.55840715 |
| 105 | Viral myocarditis_Homo sapiens_hsa05416 | 0.55567703 |
| 106 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.54049109 |
| 107 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.53372770 |
| 108 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.52375508 |
| 109 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.52282621 |
| 110 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.51682448 |
| 111 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.51578332 |
| 112 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.51529987 |
| 113 | Insulin resistance_Homo sapiens_hsa04931 | 0.51236884 |
| 114 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.50686321 |
| 115 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.49957598 |
| 116 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.49955714 |
| 117 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.49874351 |
| 118 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.49639672 |
| 119 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.47861280 |
| 120 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.47745349 |
| 121 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.47576210 |
| 122 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.47328107 |
| 123 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.46569000 |
| 124 | Bile secretion_Homo sapiens_hsa04976 | 0.46484209 |
| 125 | Prostate cancer_Homo sapiens_hsa05215 | 0.43895292 |
| 126 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.43722143 |
| 127 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.43441730 |
| 128 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.42561359 |
| 129 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.41512581 |
| 130 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.41137629 |
| 131 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.40111821 |
| 132 | Glioma_Homo sapiens_hsa05214 | 0.39210395 |
| 133 | Mineral absorption_Homo sapiens_hsa04978 | 0.38106600 |
| 134 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.37698634 |
| 135 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.36918400 |
| 136 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.36595779 |
| 137 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.35922495 |
| 138 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.35712836 |
| 139 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.34816535 |
| 140 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.34274168 |
| 141 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.32944015 |

